128 related articles for article (PubMed ID: 34597445)
1. Development of individuals with thanatophoric dysplasia surviving beyond infancy.
Ushioda M; Sawai H; Numabe H; Nishimura G; Shibahara H
Pediatr Int; 2022 Jan; 64(1):e15007. PubMed ID: 34597445
[TBL] [Abstract][Full Text] [Related]
2. Seborrhoeic keratoses and acanthosis nigricans in a long-term survivor of thanatophoric dysplasia.
Nakai K; Yoneda K; Moriue T; Munehiro A; Fujita N; Moriue J; Yokoi I; Haba R; Itoh S; Kubota Y
Br J Dermatol; 2010 Sep; 163(3):656-8. PubMed ID: 20518778
[No Abstract] [Full Text] [Related]
3. Long-term survival in typical thanatophoric dysplasia type 1.
Baker KM; Olson DS; Harding CO; Pauli RM
Am J Med Genet; 1997 Jun; 70(4):427-36. PubMed ID: 9182787
[TBL] [Abstract][Full Text] [Related]
4. National survey of prevalence and prognosis of thanatophoric dysplasia in Japan.
Sawai H; Oka K; Ushioda M; Nishimura G; Omori T; Numabe H; Kosugi S
Pediatr Int; 2019 Aug; 61(8):748-753. PubMed ID: 31247124
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical findings of a patient with thanatophoric dysplasia type I: additional finding of dicarboxylic aciduria.
Okajima K; Asai K; Niwa T; Ohki S; Sobajima H; Tyson J; Malcolm S; Wada Y
Cleft Palate Craniofac J; 2002 Mar; 39(2):246-8. PubMed ID: 11879084
[TBL] [Abstract][Full Text] [Related]
6. Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.
Soo-Kyeong J; Lee N; Bae MH; Han YM; Hee Park K; Byun SY
Fetal Pediatr Pathol; 2018 Oct; 37(5):363-371. PubMed ID: 30252581
[TBL] [Abstract][Full Text] [Related]
7. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
Tavormina PL; Bellus GA; Webster MK; Bamshad MJ; Fraley AE; McIntosh I; Szabo J; Jiang W; Jabs EW; Wilcox WR; Wasmuth JJ; Donoghue DJ; Thompson LM; Francomano CA
Am J Hum Genet; 1999 Mar; 64(3):722-31. PubMed ID: 10053006
[TBL] [Abstract][Full Text] [Related]
8. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
9. Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene.
Pokharel RK; Alimsardjono H; Takeshima Y; Nakamura H; Naritomi K; Hirose S; Onishi S; Matsuo M
Biochem Biophys Res Commun; 1996 Oct; 227(1):236-9. PubMed ID: 8858131
[TBL] [Abstract][Full Text] [Related]
10. Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation.
Jung M; Park SH
Exp Mol Pathol; 2017 Apr; 102(2):290-295. PubMed ID: 28249712
[TBL] [Abstract][Full Text] [Related]
11. Thanatophoric dysplasia type I.
Chang TK; Wang Y; Liu AM; Tung JC
Acta Paediatr Taiwan; 2001; 42(1):39-41. PubMed ID: 11270184
[TBL] [Abstract][Full Text] [Related]
12. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
Bellus GA; Bamshad MJ; Przylepa KA; Dorst J; Lee RR; Hurko O; Jabs EW; Curry CJ; Wilcox WR; Lachman RS; Rimoin DL; Francomano CA
Am J Med Genet; 1999 Jul; 85(1):53-65. PubMed ID: 10377013
[TBL] [Abstract][Full Text] [Related]
13. Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia.
Hyland VJ; Robertson SP; Flanagan S; Savarirayan R; Roscioli T; Masel J; Hayes M; Glass IA
Am J Med Genet A; 2003 Jul; 120A(2):157-68. PubMed ID: 12833394
[TBL] [Abstract][Full Text] [Related]
14. A case of thanatophoric dysplasia type 2: a novel mutation.
Gülaşı S; Atıcı A; Çelik Y
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):73-6. PubMed ID: 25800480
[TBL] [Abstract][Full Text] [Related]
15. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
16. A THANATOPHORIC DYSPLASIA TYPE I CASE WITH A FGFR3 P.R248C MUTATION AND SURVIVAL BEYOND THE NEONATAL PERIOD.
Sahin S; Ograg H; Aslan EA; Akcan AB; Turkmen MK; Moosa S; Elcioglu NH
Genet Couns; 2016; 27(4):513-517. PubMed ID: 30226972
[TBL] [Abstract][Full Text] [Related]
17. Thanatophoric dysplasia type 1 with cloverleaf skull in a dichorionic twin.
Salinas-Torres VM
Genet Couns; 2015; 26(1):61-5. PubMed ID: 26043509
[TBL] [Abstract][Full Text] [Related]
18. Thanatophoric dysplasia type 1 with temporal lobe dysplasia: Report of a case along with differential diagnosis.
Mondal A; Mandal B; Das RN; Chatterjee U; Mukherjee S
Indian J Pathol Microbiol; 2021; 64(4):776-779. PubMed ID: 34673602
[TBL] [Abstract][Full Text] [Related]
19. Markers for bone metabolism in a long-lived case of thanatophoric dysplasia.
Kuno T; Fujita I; Miyazaki S; Katsumata N
Endocr J; 2000 Mar; 47 Suppl():S141-4. PubMed ID: 10890204
[TBL] [Abstract][Full Text] [Related]
20. Thanatophoric dysplasia: roentgenographic findings and detection of a de novo mutation of FGFR3 gene in a Thai patient.
Wattanasirichaigoon D; Charoenpipop D
J Med Assoc Thai; 2006 Aug; 89(8):1287-92. PubMed ID: 17048442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
